by John A. Jenkins | Apr 9, 2025 | FDA, FOIA, Medical Devices, Pharmaceuticals
FOIAengine: Revolving Door Hits Pfizer on the Way Out The revolving door between the Food and Drug Administration and the pharmaceutical industry took another fast spin when Pfizer announced that Patrizia Cavazzoni would be returning to the company as its chief...
by Randy E. Miller | Sep 18, 2024 | FDA, FOIA, Hedge Funds, Medical Devices
FOIAengine: FDA Inspections Prompt FOIA Requests When CEO Quentin Blackford of iRhythm Technologies, Inc. (NASDAQ: IRTC) began his earnings call on August 1, his wearable heart monitor technology company had survived five years of market ups and downs and had...
by Randy E. Miller | Jul 24, 2024 | FOIA, FTC, Medical Devices, Pharmaceuticals
FOIAengine Reveals Inquiries About FTC’s Inner Workings With the Federal Trade Commission reportedly preparing to sue the three largest pharmacy benefit managers, or PBMs, over their approach to negotiating the availability and prices for drugs, we’re taking a look...
by John A. Jenkins | Jun 6, 2024 | FDA, FOIA, Law Firms, Litigation, Medical Devices
FOIAengine: Hundreds of FOIA Requests Signaled Challenge to FDA Two companies that go by the names of Triton Distribution and Vapetasia are small players in America’s fast-growing $28 billion e-cigarette market. Despite their size, they’ve become the unlikely...
by John A. Jenkins | Apr 11, 2024 | FDA, FOIA, Medical Devices
FOIAengine: As Deaths Mounted, J&J “Promised to Correct” – and Sought FDA Records Johnson & Johnson (NYSE: JNJ) proudly calls itself “the world’s largest and most diversified healthcare products company.” The company had $85 billion in sales last year, and...
by John A. Jenkins | Apr 3, 2024 | FDA, FOIA, Law Firms, Medical Devices
FOIAengine: Neuralink’s High Profile Makes It a Target It was a Musk Moment unlike any other: Two weeks ago, the first human participant in Neuralink’s brain-implant trials took the stage to show how he could play chess by imagining where he wanted the pieces to go. ...
